Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: Insights into mitochondrial-nuclear interactions

Human Molecular Genetics

Volumn 23, Issue 13, 2014, Pages 3537-3551

  Cristina Kenney, M ^a   Chwa, Marilyn ^a   Atilano, Shari R ^a   Falatoonzadeh, Payam ^a   Ramirez, Claudio ^a   Malik, Deepika ^a   Tarek, Mohamed ^a   Cáceres del Carpio, Javier ^a   Nesburn, Anthony B ^a,b   Boyer, David S ^c   Kuppermann, Baruch D ^a   Vawter, Marquis ^a   Michal Jazwinski, S ^d   Miceli, Michael ^d   Wallace, Douglas C ^e   Udar, Nitin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MITOCHONDRIAL DNA; RNA;

ALLELE; APOPTOSIS; ARTICLE; BIOENERGY; COMPARATIVE STUDY; CONTROLLED STUDY; CYBRID; DNA SEQUENCE; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR INTERACTION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; CELL NUCLEUS; GENETICS; METABOLISM; MITOCHONDRION; PHYSIOLOGY;

APOPTOSIS; CELL NUCLEUS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84902302648     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu065     Document Type: Article

References (98)

1. Wallace, D.C. (1992) Diseases of the mitochondrial DNA. Annu. Rev. Biochem., 61, 1175-1212.
2. Wallace, D.C. (1994) Mitochondrial DNA mutations in diseases of energy metabolism. J. Bioenerg. Biomembr., 26, 241-250.
3. McFarland, R. and Turnbull, D.M. (2009) Batteries not included: diagnosis and management of mitochondrial disease. J. Intern. Med., 265, 210-228.
4. Wallace, D.C., Lott, M.T. and Procaccio, V. (2007) Mitochondrial Genes in Degenerative Diseases, Cancer and Aging. Churchill Livingstone Elsevier, Philadelphis, PA.
5. Czarnecka, A.M. and Bartnik, E. (2011) The role of the mitochondrial genome in ageing and carcinogenesis. J. Aging Res., 2011, 136435.
6. Ridge, P.G., Maxwell, T.J., Corcoran, C.D., Norton, M.C., Tschanz, J.T., O'Brien, E., Kerber, R.A., Cawthon, R.M., Munger, R.G. and Kauwe, J.S. (2012) Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroupsH6A1A/H6A1B: the Cache County Study on Memory in Aging. PLoS ONE, 7, e45134.
7. Strauss, K.A., DuBiner, L., Simon, M., Zaragoza, M., Sengupta, P.P., Li, P., Narula, N., Dreike, S., Platt, J., Procaccio, V. et al. (2013) Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup. Proc. Natl. Acad. Sci. USA, 110, 3453-3458.
8. De Luca, A., Nasi, M., Di Giambenedetto, S., Cozzi-Lepri, A., Pinti, M., Marzocchetti, A., Mussini, C., Fabbiani, M., Bracciale, L., Cauda, R. et al. (2012) Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy. J. Acquir. Immune Defic. Syndr., 59, 113-120.
9. Fernandez-Caggiano, M., Barallobre-Barreiro, J., Rego-Perez, I., Crespo-Leiro, M.G., Paniagua, M.J., Grille, Z., Blanco, F.J. and Domenech, N. (2013) Mitochondrial DNA haplogroup H as a risk factor for idiopathic dilated cardiomyopathy in Spanish population. Mitochondrion, 13, 263-268.
10. Canter, J.A., Kallianpur, A.R. and Fowke, J.H. (2006) Re: North American white mitochondrial haplogroups in prostate and renal cancer. J. Urol., 176, 2308-2309; author reply 2309.
11. Alvarez-Cubero, M.J., Saiz Guinaldo, M., Martinez-Gonzalez, L.J., Alvarez Merino, J.C., Cozar Olmo, J.M. and Acosta, J.A. (2012) Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population. PLoS ONE, 7, e41201.
12. Mueller, E.E., Eder, W., Mayr, J.A., Paulweber, B., Sperl, W., Horninger, W., Klocker, H. and Kofler, B. (2009) Mitochondrial haplogroups and control region polymorphisms are not associated with prostate cancer in Middle European Caucasians. PLoS ONE, 4, e6370.
13. Kim, W., Yoo, T.K., Shin, D.J., Rho, H.W., Jin, H.J., Kim, E.T. and Bae, Y.S. (2008) Mitochondrial DNA haplogroup analysis reveals no association between the common genetic lineages and prostate cancer in the Korean population. PLoS ONE, 3, e2211.
14. Pichaud, N., Ballard, J.W., Tanguay, R.M. and Blier, P.U. (2012) Naturally occurring mitochondrial DNA haplotypes exhibit metabolic differences:insight into functional properties of mitochondria. Evolution, 66, 3189-3197.
15. Tranah, G.J. (2011) Mitochondrial-nuclear epistasis: implications for human aging and longevity. Ageing Res. Rev., 10, 238-252.
16. Meiklejohn, C.D., Holmbeck, M.A., Siddiq, M.A., Abt, D.N., Rand, D.M. and Montooth, K.L. (2013) An Incompatibility between a mitochondrial tRNA and its nuclear-encoded tRNA synthetase compromises development and fitness in Drosophila. PLoS Genet., 9, e1003238.
17. Pichaud, N., Ballard, J.W., Tanguay, R.M. and Blier, P.U. (2013) Mitochondrial haplotype divergences affect specific temperature sensitivity of mitochondrial respiration. J. Bioenerg. Biomembr., 45, 25-35.
18. Houtkooper, R.H., Mouchiroud, L., Ryu, D., Moullan, N., Katsyuba, E., Knott, G., Williams, R.W. and Auwerx, J. (2013) Mitonuclear protein imbalance as a conserved longevity mechanism. Nature, 497, 451-457.
19. Mueller, E.E., Brunner, S.M., Mayr, J.A., Stanger, O., Sperl, W. and Kofler, B. (2012) Functional differences between mitochondrial haplogroup T and haplogroup H in HEK293 cybrid cells. PLoS ONE, 7, e52367.
20. Bellizzi, D., D'Aquila, P., Giordano, M., Montesanto, A. and Passarino, G. (2012) Global DNA methylation levels are modulated by mitochondrial DNA variants. Epigenomics, 4, 17-27.
21. Brown, M.D., Trounce, I.A., Jun, A.S., Allen, J.C. and Wallace, D.C. (2000) Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. J. Biol. Chem., 275, 39831-39836.
22. Pacheu-Grau, D., Gomez-Duran, A., Iglesias, E., Lopez-Gallardo, E., Montoya, J. and Ruiz-Pesini, E. (2013) Mitochondrial antibiograms in personalized medicine. Hum. Mol. Genet., 22, 1132-1139.
23. Jones, M.M., Manwaring, N., Wang, J.J., Rochtchina, E., Mitchell, P. and Sue, C.M. (2007) Mitochondrial DNA haplogroups and age-related maculopathy. Arch. Ophthalmol., 125, 1235-1240.
24. Canter, J.A., Olson, L.M., Spencer, K., Schnetz-Boutaud, N., Anderson, B., Hauser, M.A., Schmidt, S., Postel, E.A., Agarwal, A., Pericak-Vance, M.A. et al. (2008) Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS ONE, 3, e2091.
25. Udar, N., Atilano, S.R., Memarzadeh, M., Boyer, D., Chwa, M., Lu, S., Maguen, B., Langberg, J., Coskun, P., Wallace, D.C. et al. (2009) Mitochondrial DNA haplogroups associated with Age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 50, 2966-2974.
26. SanGiovanni, J.P., Arking, D.E., Iyengar, S.K., Elashoff, M., Clemons, T.E., Reed, G.F., Henning, A.K., Sivakumaran, T.A., Xu, X., DeWan, A. et al. (2009) Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS ONE, 4, e5508.
27. Mueller, E.E., Schaier, E., Brunner, S.M., Eder, W., Mayr, J.A., Egger, S.F., Nischler, C., Oberkofler, H., Reitsamer, H.A., Patsch, W. et al. (2012) Mitochondrial haplogroups and control region polymorphisms in age-related macular degeneration: a case-control study. PLoS ONE, 7, e30874.
28. Martinez-Redondo, D., Marcuello, A., Casajus, J.A., Ara, I., Dahmani, Y., Montoya, J., Ruiz-Pesini, E., Lopez-Perez, M.J. and Diez-Sanchez, C. (2010) Human mitochondrial haplogroup H: the highest VO2max consumer--is it a paradox?. Mitochondrion, 10, 102-107.
29. Marcuello, A., Martinez-Redondo, D., Dahmani, Y., Casajus, J.A., Ruiz-Pesini, E., Montoya, J., Lopez-Perez, M.J. and Diez-Sanchez, C. (2009) Human mitochondrial variants influence on oxygen consumption. Mitochondrion, 9, 27-30.
30. De Benedictis, G., Rose, G., Carrieri, G., De Luca, M., Falcone, E., Passarino, G., Bonafe, M., Monti, D., Baggio, G., Bertolini, S. et al. (1999) Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J., 13, 1532-1536.
31. Niemi, A.K., Hervonen, A., Hurme, M., Karhunen, P.J., Jylha, M. and Majamaa, K. (2003) Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum. Genet., 112, 29-33.
32. Ross, O.A., McCormack, R., Curran, M.D., Duguid, R.A., Barnett, Y.A., Rea, I.M. and Middleton, D. (2001) Mitochondrial DNA polymorphism: its role in longevity of the Irish population. Exp. Gerontol., 36, 1161-1178.
33. Gomez-Duran, A., Pacheu-Grau, D., Martinez-Romero, I., Lopez-Gallardo, E., Lopez-Perez, M.J., Montoya, J. and Ruiz-Pesini, E. (2012) Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. Biochim. Biophys. Acta, 1822, 1216-1222.
34. Kenney, M.C., Chwa, M., Atilano, S.R., Pavlis, J.M., Falatoonzadeh, P., Ramirez, C., Malik, D., Hsu, T., Woo,G., Soe, K. et al. (2013) Mitochondrial DNAvariants mediate energy production and expression levels for CFH, C3, and EFEMP1 genes: Implications for age-related macular degeneration. PLoS ONE, 8, e54339-e54348.
35. Ratnapriya, R. and Chew, E.Y. (2013) Age-related macular degeneration-clinical review and genetics update. Clin. Genet., 84, 160-166.
36. Reynolds, R., Rosner, B. and Seddon, J.M. (2013) Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Ophthalmology, 120, 1020-1028.
37. van der Walt, J.M., Dementieva, Y.A., Martin, E.R., Scott, W.K., Nicodemus, K.K., Kroner, C.C., Welsh-Bohmer, K.A., Saunders, A.M., Roses, A.D., Small, G.W. et al. (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci. Lett., 365, 28-32.
38. van der Walt, J.M., Nicodemus, K.K., Martin, E.R., Scott, W.K., Nance, M.A., Watts, R.L., Hubble, J.P., Haines, J.L., Koller, W.C., Lyons, K. et al. (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet., 72, 804-811.
39. Huerta, C., Castro, M.G., Coto, E., Blazquez, M., Ribacoba, R., Guisasola, L.M., Salvador, C., Martinez, C., Lahoz, C.H. and Alvarez, V. (2005) Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. J. Neurol. Sci., 236, 49-54.
40. Coskun, P., Wyrembak, J., Schriner, S., Chen, H.W., Marciniack, C., Laferla, F. and Wallace, D.C. (2012) Amitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta, 1820, 553-564.
41. Fernandez-Moreno, M., Soto-Hermida, A., Oreiro, N., Pertega, S., Fenandez-Lopez, C., Rego-Perez, I. and Blanco, F.J. (2012) Mitochondrial haplogroups define two phenotypes of osteoarthritis. Front. Physiol., 3, 129.
42. D'Aquila, P., Rose, G., Panno, M.L., Passarino, G. and Bellizzi, D. (2012) SIRT3 gene expression: a link between inherited mitochondrial DNA variants and oxidative stress. Gene, 497, 323-329.
43. Arning, L., Haghikia, A., Taherzadeh-Fard, E., Saft, C., Andrich, J., Pula, B., Hoxtermann, S., Wieczorek, S., Akkad, D.A., Perrech, M. et al. (2010) Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J. Mol. Med. (Berl.), 88, 431-436.
44. Gomez-Duran, A., Pacheu-Grau, D., Lopez-Gallardo, E., Diez-Sanchez, C., Montoya, J., Lopez-Perez, M.J. and Ruiz-Pesini, E. (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum. Mol. Genet., 19, 3343-3353.
45. Kenney, M.C., Chwa, M., Atilano, S.R., Falatoonzadeh, P., Ramirez, C., Malik, D., Tarek, M., Del Carpio, J.C., Nesburn, A.B., Boyer, D.S. et al. (2014) Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases. Biochim. Biophys. Acta, 1842, 208-219.
46. Ruiz-Pesini, E., Mishmar, D., Brandon, M., Procaccio, V. and Wallace, D.C. (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA. Science, 303, 223-226.
47. Pierron, D., Rocher, C., Amati-Bonneau, P., Reynier, P., Martin-Negrier, M.L., Allouche, S., Batandier, C., Mousson de Camaret, B., Godinot, C., Rotig, A. et al. (2008) New evidence of a mitochondrial genetic background paradox: impact of the J haplogroup on the A3243G mutation. BMC. Med. Genet., 9, 41.
48. Pierron, D., Chang, I., Arachiche, A., Heiske, M., Thomas, O., Borlin, M., Pennarun, E., Murail, P., Thoraval, D., Rocher, C. et al. (2011) Mutation rate switch inside Eurasian mitochondrial haplogroups: impact of selection and consequences for dating settlement in Europe. PLoS ONE, 6, e21543.
49. Reynolds, R., Hartnett, M.E., Atkinson, J.P., Giclas, P.C., Rosner, B. and Seddon, J.M. (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest. Ophthalmol. Vis. Sci., 50, 5818-5827.
50. Haines, J.L., Hauser, M.A., Schmidt, S., Scott, W.K., Olson, L.M., Gallins, P., Spencer, K.L., Kwan, S.Y., Noureddine, M., Gilbert, J.R. et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science, 308, 419-421.
51. Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C., Henning, A.K., Sangiovanni, J.P., Mane, S.M., Mayne, S.T. et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science, 308, 385-389.
52. Hageman, G.S., Anderson, D.H., Johnson, L.V., Hancox, L.S., Taiber, A.J., Hardisty, L.I., Hageman, J.L., Stockman, H.A., Borchardt, J.D., Gehrs, K.M. et al. (2005)Acommon haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA, 102, 7227-7232.
53. Gold, B., Merriam, J.E., Zernant, J., Hancox, L.S., Taiber, A.J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G.R. et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet., 38, 458-462.
54. Edwards, A.O., Ritter, R. 3rd, Abel, K.J., Manning, A., Panhuysen, C. and Farrer, L.A. (2005) Complement factor H polymorphism and age-related macular degeneration. Science, 308, 421-424.
55. Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M.J. and Seddon, J.M. (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet., 38, 1055-1059.
56. Maller, J.B., Fagerness, J.A., Reynolds, R.C., Neale, B.M., Daly, M.J. and Seddon, J.M. (2007) Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet., 39, 1200-1201.
57. Fagerness, J.A., Maller, J.B., Neale, B.M., Reynolds, R.C., Daly, M.J. and Seddon, J.M. (2009) Variation near complement factor I is associated with risk of advanced AMD. Eur. J. Hum. Genet., 17, 100-104.
58. Hudson, G., Carelli, V., Spruijt, L., Gerards, M., Mowbray, C., Achilli, A., Pyle, A., Elson, J., Howell, N., La Morgia, C. et al. (2007) Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am. J. Hum. Genet., 81, 228-233.
59. Ferreira, I.L., Nascimento, M.V., Ribeiro, M., Almeida, S., Cardoso, S.M., Grazina, M., Pratas, J., Santos, M.J., Januario, C., Oliveira, C.R. et al. (2010) Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Exp. Neurol., 222, 243-255.
60. Jun, A.S., Trounce, I.A., Brown, M.D., Shoffner, J.M. and Wallace, D.C. (1996) Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol. Cell. Biol., 16, 771-777.
61. Anderson, D.H., Radeke, M.J., Gallo, N.B., Chapin, E.A., Johnson, P.T., Curletti, C.R., Hancox, L.S., Hu, J., Ebright, J.N., Malek, G. et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res., 29, 95-112.
62. Fett, A.L., Hermann, M.M., Muether, P.S., Kirchhof, B. and Fauser, S. (2012) Immunohistochemical localization of complement regulatory proteins in the human retina. Histol. Histopathol., 27, 357-364.
63. Bellizzi, D., Taverna, D., D'Aquila, P., De Blasi, S. and De Benedictis, G. (2009) Mitochondrial DNA variability modulates mRNA and intra-mitochondrial protein levels of HSP60 and HSP75: experimental evidence from cybrid lines. Cell Stress Chaperones, 14, 265-271.
64. Bellizzi, D., Cavalcante, P., Taverna, D., Rose, G., Passarino, G., Salvioli, S., Franceschi, C. and De Benedictis, G. (2006) Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines. Genes Cells, 11, 883-891.
65. Fassio, J.B., Brockman, E.B., Jumblatt, M., Greaton, C., Henry, J.L., Geoghegan, T.E., Barr, C. and Schultz, G.S. (1989) Transforming growth factor alpha and its receptor in neural retina. Invest. Ophthalmol. Vis. Sci., 30, 1916-1922.
66. Lillien, L. and Cepko, C. (1992) Control of proliferation in the retina:temporal changes in responsiveness to FGF and TGF alpha. Development, 115, 253-266.
67. Anchan, R.M., Reh, T.A., Angello, J., Balliet, A. and Walker,M. (1991) EGF and TGF-alpha stimulate retinal neuroepithelial cell proliferation in vitro. Neuron, 6, 923-936.
68. Sagar, S.M., Edwards, R.H. and Sharp, F.R. (1991) Epidermal growth factor and transforming growth factor alpha induce c-fos gene expression in retinal Muller cells in vivo. J. Neurosci. Res., 29, 549-559.
69. Murphy, G.E., Xu, D., Liew, F.Y. and McInnes, I.B. (2010) Role of interleukin 33 in human immunopathology. Ann. Rheum. Dis. 69 (Suppl. 1), i43-i47.
70. Liew, F.Y. (2012) IL-33: a Janus cytokine. Ann. Rheum. Dis., 71(Suppl. 2), i101-i104.
71. Kuchler, A.M., Pollheimer, J., Balogh, J., Sponheim, J., Manley, L., Sorensen, D.R., De Angelis, P.M., Scott, H. and Haraldsen, G. (2008) Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am. J. Pathol., 173, 1229-1242.
72. Komai-Koma, M., Xu, D., Li, Y., McKenzie, A.N., McInnes, I.B. and Liew, F.Y. (2007) IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol., 37, 2779-2786.
73. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T.K., Zurawski, G., Moshrefi, M., Qin, J., Li, X. et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity, 23, 479-490.
74. Smithgall, M.D., Comeau, M.R., Yoon, B.R., Kaufman, D., Armitage, R. and Smith, D.E. (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol., 20, 1019-1030.
75. Miller, A.M., Xu, D., Asquith, D.L., Denby, L., Li, Y., Sattar, N., Baker, A.H., McInnes, I.B. and Liew, F.Y. (2008) IL-33 reduces the development of atherosclerosis. J. Exp. Med., 205, 339-346.
76. Rank, M.A., Kobayashi, T., Kozaki, H., Bartemes, K.R., Squillace, D.L. and Kita, H. (2009) IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol., 123, 1047-1054.
77. Carriere, V., Roussel, L., Ortega, N., Lacorre, D.A., Americh, L., Aguilar, L., Bouche, G. and Girard, J.P. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA, 104, 282-287.
78. Leung, B.P., Xu, D., Culshaw, S., McInnes, I.B. and Liew, F.Y. (2004) A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J. Immunol., 173, 145-150.
79. Seidelin, J.B., Bjerrum, J.T., Coskun, M., Widjaya, B., Vainer, B. and Nielsen, O.H. (2010) IL-33 is upregulated in colonocytes of ulcerative colitis. Immunol. Lett., 128, 80-85.
80. Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C.J., Ying, S., Pitman, N., Mirchandani, A., Rana, B., van Rooijen, N. et al. (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol., 183, 6469-6477.
81. Tuo, J., Grob, S., Zhang, K. and Chan, C.C. (2012) Genetics of immunological and inflammatory components in age-related macular degeneration. Ocular Immunol. Inflamm., 20, 27-36.
82. Liu, X.C., Liu, X.F., Jian, C.X., Li, C.J. and He, S.Z. (2012) IL-33 is induced by amyloid-beta stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells. Inflammation, 35, 776-784.
83. Iriyama, A., Fujiki, R., Inoue, Y., Takahashi, H., Tamaki, Y., Takezawa, S., Takeyama, K., Jang, W.D., Kato, S. and Yanagi, Y. (2008) A2E,a pigment of the lipofuscin of retinal pigment epithelial cells, is an endogenous ligand for retinoic acid receptor. J. Biol. Chem., 283, 11947-11953.
84. Iriyama, A., Inoue, Y., Takahashi, H., Tamaki, Y., Jang, W.D. and Yanagi, Y. (2009) A2E, a component of lipofuscin, is pro-angiogenic in vivo. J. Cell. Physiol., 220, 469-475.
85. Finnemann, S.C., Leung, L.W. and Rodriguez-Boulan, E. (2002) The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc. Natl. Acad. Sci. USA, 99, 3842-3847.
86. Suter, M., Reme, C., Grimm, C., Wenzel, A., Jaattela,M., Esser, P., Kociok, N., Leist,M. and Richter, C. (2000) Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins frommitochondria andinduces apoptosis inmammalian retinal pigment epithelial cells. J. Biol. Chem., 275, 39625-39630.
87. Bergmann, M., Schutt, F., Holz, F.G. and Kopitz, J. (2004) Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J., 18, 562-564.
88. Sparrow, J.R., Nakanishi, K. and Parish, C.A. (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci., 41, 1981-1989.
89. Holleman, A., den Boer, M.L., de Menezes, R.X., Cheok, M.H., Cheng, C., Kazemier, K.M., Janka-Schaub, G.E., Gobel, U., Graubner, U.B., Evans, W.E. et al. (2006) The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood, 107, 769-776.
90. Yang, Y.L., Lin, S.R., Chen, J.S., Lin, S.W., Yu, S.L., Chen, H.Y., Yen, C.T., Lin, C.Y., Lin, J.F., Lin, K.H. et al. (2010) Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia. Leuk. Res., 34, 18-23.
91. Kataoka, T., Holler, N., Micheau, O., Martinon, F., Tinel, A., Hofmann, K. and Tschopp, J. (2001) Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. J. Biol. Chem., 276, 19548-19554.
92. Jazwinski, S.M. and Kriete, A. (2012) The yeast retrograde response as a model of intracellular signaling of mitochondrial dysfunction. Front. Physiol., 3, 139.
93. Ballinger, S.W. (2013) Beyond retrograde and anterograde signalling:mitochondrial-nuclear interactions as a means for evolutionary adaptation and contemporary disease susceptibility. Biochem. Soc. Trans., 41, 111-117.
94. Nargund, A.M., Pellegrino, M.W., Fiorese, C.J., Baker, B.M. and Haynes, C.M. (2012) Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science, 337, 587-590.
95. Dunn, K.C., Marmorstein, A.D., Bonilha, V.L., Rodriguez-Boulan, E., Giordano, F. and Hjelmeland, L.M. (1998) Use of the ARPE-19 cell line as a model of RPE polarity: basolateral secretion of FGF5. Invest. Ophthalmol. Vis. Sci., 39, 2744-2749.
96. Miceli, M.V. and Jazwinski, S.M. (2005) Nuclear gene expression changes due to mitochondrial dysfunction in ARPE-19 cells: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 46, 1765-1773.
97. Chomyn, A. (1996) Platelet-mediated Transformation of Human Mitochondrial DNA-Less Cells. Academic Press, Inc., Salt Lake City, UT.
98. Zaragoza, M.V., Brandon, M.C., Diegoli, M., Arbustini, E. and Wallace, D.C. (2011) Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny. Eur. J. Hum. Genet., 19, 200-207.